Abstract
Supplementary Fig. from The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have